Welcome to the Healthcare Diversity Council! Here we strongly believe in a global representation in hospitals and clinics across the country, that every healthcare institution should mirror the environment and patients that it serves.
There are many opportunities to volunteer your time and talent in creating greater diversity and inclusion in Healthcare. Our volunteers get involved in all aspects of event planning and implementation, as well as outreach, communication, and advocacy within their organization and the community…
Health Equity: Lessons from AcademyHealth 2020
by Alexa Ortiz & Monika Gulledge
Health equity and the disparities within our health care system were the predominant themes at AcademyHealth’s 2020 Annual Research Meeting (ARM), which concluded on August 6th. As usual, health services researchers gathered to disseminate the latest evidence across a broad range of health care topics and discuss the most pressing issues in health services research… Read More » Author information Alexa Ortiz Health IT Scientist at RTI International Alexa Ortiz graduated from the University of North Carolina at Charlotte in 2009 with a Bachelor of Science in Nursing. Before receiving her graduate degree she was a practicing nurse for five years and has clinical experience in the field of both Cardiology and Neurology. In 2014 she received a Master of Science in Nursing specializing in nursing informatics from Duke University. Presently, she works as a Health IT Scientist at RTI International in the Center for Digital Health and Clinical Informatics. Despite no longer working in a clinical setting, she continues to maintain an active nurse license in the state of North Carolina. Her primary areas of research at RTI International focus on the clinical implementation of health information technology and the evaluation of consumer wearable devices. | Twitter | The post Health Equity: Lessons from AcademyHealth 2020 appeared first on The Medical Care Blog.
Potential effects of COVID-19 on health care utilization and quality measures
by Amarilys Bernacet, Ye Zhang, Ryan Nguyen, Musetta Leung, Laura Smith
What are the potential impacts of COVID-19 on health care utilization? How will changes in healthcare use impact quality measures? Researchers are asking many key questions to understand the impacts of COVID-19. It is clear that trends in healthcare use are changing. These changes will likely affect quality measure scores in the future. This is… Read More » Author information Amarilys Bernacet Amarilys Bernacet is a research public health analyst in the Quality Measurement and Health Policy group within the eHealth, Quality, and Analytics Division. She has experience in health policy research and has a beneficiary advocacy and policy background in Medicaid, Medicare, and federal low-income programs. Ms. Bernacet works on several program evaluation and implementation projects. She is currently leading analyses of potential impacts of the pandemic on claims data and quality measure performance scores on one of her project task teams. | The post Potential effects of COVID-19 on health care utilization and quality measures appeared first on The Medical Care Blog.
Behavioral Health: Actuarial Value, Integration, & Innovation
by John M. Westfall and David Napoli
Behavioral health — counseling, mental health care, and care for substance use issues — is one of the basic benefits associated with health insurance and healthcare delivery. The COVID-19 pandemic has reminded us of the gross inadequacy of current behavioral health to deliver high quality care to most Americans. The past 30 years of health… Read More » Author information Jack Westfall Director - Robert Graham Center at AAFP Jack Westfall is a family doctor in Washington, DC and Director of the Robert Graham Center for Policy Studies in Family Medicine and Primary Care. He completed his MD and MPH at the University of Kansas School of Medicine, an internship in hospital medicine in Wichita, Kansas, and his Family Medicine Residency at the University of Colorado Rose Family Medicine Program. After joining the faculty at the University of Colorado Department of Family Medicine, Dr Westfall started the High Plains Research Network, a geographic community and practice-based research network in rural and frontier Colorado. He practiced family medicine in several rural communities including Limon, Ft Morgan, and his home town of Yuma, Colorado. Dr Westfall was on the faculty of the University of Colorado for over 20 years, including serving as Associate Dean for Rural Health, Director of Community Engagement for the Colorado Clinical Translational Science Institute, AHEC Director, and Sr Scholar at the Farley Health Policy Center. He just completed two years as the Medical Director for Whole Person Care and Health Communities at the Santa Clara County Health and Hospital and Public Health Department. His research interests include rural health, linking primary care and community health, and policies aimed at assuring a robust primary care workforce for rural, urban, and vulnerable communities. | LinkedIn | The post Behavioral Health: Actuarial Value, Integration, & Innovation appeared first on The Medical Care Blog.
Options for Universal Coverage: Part 3 – Increasing Medicare Benefits
by Benjamin Silver and Brett Lissenden
In this series on options for universal coverage, we explore elements of various reform proposals and evaluate their potential impact. Rather than examining complete proposals, we highlight specific policy elements that appear in one or more such proposals. The three we focus on in this series are: Eliminating Medicare Advantage (May 14, 2020) Expanding Medicare… Read More » Author information Benjamin Silver Program Manager and Research Economist at RTI International Benjamin Silver is a Research Health Economist and a program manager in the Health Care Financing and Payment Program at RTI International. His current work includes government funded health policy research designign and implementing value-based alternative payment models on behalf of the Centers for Medicare & Medicaid Services and the Medicare Payment Advisory Commission. Dr. Silver also holds faculty appointments at Brown University and at Wheaton College, where he has taught undergraduate courses in U.S. public health policy. | LinkedIn | The post Options for Universal Coverage: Part 3 – Increasing Medicare Benefits appeared first on The Medical Care Blog.
Pandemic PPE Waste: An Environmental Health Educational Opportunity
by Evelyn Alvarez
In our battle against COVID-19, one of our unique challenges is the use of face-coverings. Despite evidence that supports wearing face coverings, this has become a polarizing issue in a highly politically-divided climate. After shifting mask guidance in the early days of the pandemic, the WHO and the CDC issued formal guidelines on wearing face… Read More » Author information Evelyn Alvarez Professor at Cal State LA Dr. Evelyn Alvarez, MPH is a first generation college graduate who recently completed a PhD in environmental health science at UCLA where she focused on the hospital environment and antimicrobials, hospital-acquired infections, and pediatric isolation. She earned her MPH in environmental health sciences from Columbia University. Her research interests also include examining underrepresented narratives in the climate change dialogue and making sustainability more accessible to lower socio-economic populations. She also plays contrabass for the Cal State LA Symphony Orchestra. | Twitter | LinkedIn | The post Pandemic PPE Waste: An Environmental Health Educational Opportunity appeared first on The Medical Care Blog.
Food + Mental & Physical Health
by Colin Hung
I was listening to the radio while running errands this weekend when I heard a local DJ lament the 10lbs he had gained since the pandemic lock-down started in March. He gained the weight despite running and biking regularly to replace his gym time. He chalked up his additional weight to the comfort food he
Hope Still Matters
by Joe Babaian
Blog Post by Joe Babaian Hope matters. You matter. During this time of Pandemic and continued national stress, let’s talk about hope. At #hcldr we spend all of our time talking and listening to everyone we meet in healthcare and other fields. We see the opportunities to bring people together, listening to many points of
More Than a Visitor – Essential Caregivers During COVID-19 Are Vital
by Colin Hung
The COVID-19 pandemic has exposed many gaps in healthcare systems around the world. No country or health system has been spared the harsh spotlight. Yet over the last few months, there has been one gap that has not gotten a lot of press – the lack of access of caregivers to their loved ones in
Surviving The Pandemic’s 4th Wave
by Joe Babaian
Blog Post by Joe Babaian Today’s blog is circling back to our discussion on April 7th as we discussed the impending 4th Wave of the pandemic. Well here it is September and not only are there multiple waves of the pandemic still ongoing, but the 4th Wave as we described is here as well
Face Masks: Learning a Better Way From History
by Colin Hung
For the past few months, a phrase my Grade 5 history teacher, Mrs. Galbraith, has been stuck my head: “History repeats itself, but only for those that are open minded enough to see it.” We were learning about the influx of Irish refugees to Canada and the US who were fleeing the Potato Famine in
Tobacco responsible for 20% of deaths from coronary heart disease
Every year, 1.9 million people die from tobacco-induced heart disease, according to a new brief released today by the World Health Organization, World Heart Federation and the University of Newcastle Australia ahead of World Heart Day, marked on 29 September.This equates to one in five of all deaths from heart disease, warn the report’s authors, who urge all tobacco users to quit and avoid a heart attack, stressing that smokers are more likely to experience an acute cardiovascular event at a younger age than non-smokers.Just a few cigarettes a day, occasional smoking, or exposure to second-hand smoke increase the risk of heart disease. But if tobacco users take immediate action and quit, then their risk of heart disease will decrease by 50% after one year of not smoking.“Given the current level of evidence on tobacco and cardiovascular health and the health benefits of quitting smoking, failing to offer cessation services to patients with heart disease could be considered clinical malpractice or negligence. Cardiology societies should train their members in smoking cessation, as well as to promote and even drive tobacco control advocacy efforts,” said Dr Eduardo Bianco, Chair of the World Heart Federation Tobacco Expert Group.The brief also shows that smokeless tobacco is responsible for around 200 000 deaths from coronary heart disease per year. E-cigarettes also raise blood pressure increasing the risk of cardiovascular disease.Moreover, high blood pressure and heart disease increase the risk of severe COVID-19. A recent WHO survey found that among people dying of COVID-19 in Italy, 67% had high blood pressure and in Spain, 43% of people who developed COVID-19 were living with heart disease.“Governments have a responsibility to protect the health of their people and help reverse the tobacco epidemic. Making our communities smoke-free reduces the number of tobacco-related hospital admissions, which is more important than ever in the context of the current pandemic,” said Dr Vinayak Prasad, Unit Lead of the WHO No Tobacco Unit.Tobacco control is a key element for reducing heart disease. Governments can help tobacco users quit by increasing tax on tobacco products, enforcing bans on tobacco advertising and offering services to help people give up tobacco.
WHO and UNICEF recommit to accelerating health and well-being at all ages
The World Health Organization (WHO) and UNICEF today signed a new collaborative framework which will accelerate joint public health efforts that put the most marginalized and vulnerable populations first.The new Strategic Collaboration Framework builds on a robust 70-year collaboration between the two organizations, and prioritizes four strategic areas for immediate attention and action at all levels of the organizations: universal health coverage, through a primary health care and health systems approach; mental health and psychosocial wellbeing and development; public health emergencies; and maternal and child nutrition.Additionally, the two organizations signed a new Joint Programme on Mental Health and Psychosocial Well-being and Development of Children and Adolescents. This 10-year collaborative effort will promote mental health and psychosocial well-being and development, increase access to care for mental health conditions, reduce suffering and enhance quality of life among children and adolescents, and their caregiversBoth organizations are particularly concerned about the urgent need to better tackle issues affecting adolescents. Depression is is one of the leading causes of illness and disability among adolescents, and suicide is the second leading cause of death in adolescents.“The COVID-19 pandemic has exposed huge gaps in accessing health, well-being and nutrition services among children and vulnerable populations,” said Henrietta Fore, UNICEF Executive Director. “There has never been a more urgent need to work together. This new framework will help us strengthen health and food systems, and invest in mental health and psychosocial support in every country in the world.” For more than 70 years, WHO and UNICEF have worked together worldwide to ensure children survive and thrive, and benefit from a safe and clean environment. The two organizations collaborated to provide high-impact health, immunization, nutrition, HIV and early child development interventions, as well as safe water and sanitation services in every region of the world, including in fragile and conflict settings."At the heart of our work with UNICEF is seeing that every child not only survives but ultimately thrives and transforms their communities and future generations," said Dr Tedros Adhanom Ghebreyesus, WHO Director-General. "With great appreciation and respect for our unique and complementary roles, we stand together in our commitment to achieve health for all. As this pandemic demonstrates, no-one is safe until everyone is safe.”Today, WHO and UNICEF continue to work together to stop the COVID-19 pandemic and ensure that every woman and every child have access to the essential health services they need, including immunizations and health check-ups.The two organizations are also working together to support countries to introduce and deliver COVID-19 vaccines under the vaccines pillar of the “Access to COVID-19 Tools – Accelerator” (ACT-A) initiative, along with Gavi, CEPI and global immunization partners.Additionally, the organizations are strengthening health systems through primary health care, as agreed in the Declaration of Astana, and the UN High-level declaration on UHC, in order to accelerate achievement of universal health coverage and Sustainable Development Goal 3 targets by 2030.The World Health OrganizationThe World Health Organization provides global leadership in public health within the United Nations system. Founded in 1948, WHO works with 194 Member States, across six regions and from more than 150 offices, to promote health, keep the world safe and serve the vulnerable. Our goal for 2019-2023 is to ensure that a billion more people have universal health coverage, to protect a billion more people from health emergencies, and provide a further billion people with better health and wellbeing.For updates on COVID-19 and public health advice to protect yourself from coronavirus, visit www.who.int and follow WHO on Twitter, Facebook, Instagram, LinkedIn, TikTok, Pinterest, Snapchat, YouTubeUNICEFUNICEF works in some of the world’s toughest places, to reach the world’s most disadvantaged children. Across 190 countries and territories, we work for every child, everywhere, to build a better world for everyone. For more information about UNICEF and its work for children, visit www.unicef.org. For more information about COVID-19, visit www.unicef.org/coronavirus. Follow UNICEF on Twitter and Facebook.
Boost for global response to COVID-19 as economies worldwide formally sign up to COVAX facility
64 higher income economies have now joined the COVAX Facility, with a further 38 economies expected to sign in the coming days These self-financing economies, which include 29 from ‘Team Europe’ participating as part of an agreement with the European Commission, join 92 lower income economies eligible for financial support through the Gavi COVAX Advance Market CommitmentThis means a total of 156 economies, representing nearly two-thirds of the global population, are now committed to or eligible to receive vaccines through the Facility Click here for the list of economies64 higher income economies have joined the COVAX Facility, a global initiative that brings together governments and manufacturers to ensure eventual COVID-19 vaccines reach those in greatest need, whoever they are and wherever they live. These 64 economies include commitments from 35 economies as well as the European Commission which will procure doses on behalf of 27 EU member states plus Norway and Iceland. By pooling financial and scientific resources, these participating economies will be able to insure themselves against the failure of any individual vaccine candidate and secure successful vaccines in a cost-effective, targeted way. The 64 members of the Facility will be joined by 92 low- and middle-income economies eligible for support for the procurement of vaccines through the Gavi COVAX Advance Market Commitment (AMC), a financing instrument aimed at supporting the procurement of vaccines for these countries. This means that 156 economies, representing roughly 64% of the global population in total, are now either committed to or eligible for the COVAX Facility, with more to follow.With the Commitment Agreements secured, the COVAX Facility will now start signing formal agreements with vaccine manufacturers and developers, which are partners in the COVAX effort, to secure the doses needed to end the acute phase of the pandemic by the end of 2021. This is in addition to an ongoing effort to raise funding for both R&D and for the procurement of vaccines for lower-income countries via the Gavi COVAX AMC.“COVAX is now in business: governments from every continent have chosen to work together, not only to secure vaccines for their own populations, but also to help ensure that vaccines are available to the most vulnerable everywhere,” said Dr Seth Berkley, CEO of Gavi, the Vaccine Alliance, which is coordinating the COVAX Facility. “With the commitments we’re announcing today for the COVAX Facility, as well as the historic partnership we are forging with industry, we now stand a far better chance of ending the acute phase of this pandemic once safe, effective vaccines become available.”The COVAX Facility is part of COVAX, the vaccines pillar of the Access to COVID-19 Tools (ACT) Accelerator, which is co-led by the Coalition for Epidemic Preparedness Innovations (CEPI), Gavi, the Vaccine Alliance, and the World Health Organization (WHO) – working in partnership with developed and developing country vaccine manufacturers, UNICEF, the World Bank, Civil Society Organisations and others. The allocation of vaccines, once licensed and approved, will be guided by an Allocation Framework released today by WHO following the principle of fair and equitable access, ensuring no participating economy will be left behind. Policies determining the prioritization of vaccine rollout within economies will be guided by recommendations from the WHO Strategic Advisory Group of Experts on Immunization (SAGE), which has recently released a Values Framework laying the groundwork for subsequent guidance on target populations and policies on vaccine use. “COVID-19 is an unprecedented global crisis that demands an unprecedented global response,” said WHO Director-General, Dr Tedros Adhanom Ghebreyesus. “Vaccine nationalism will only perpetuate the disease and prolong the global recovery. Working together through the COVAX Facility is not charity, it’s in every country’s own best interests to control the pandemic and accelerate the global economic recovery.”The commitment of fully self-financing economies will now unlock vital funding and the security of demand needed to scale up manufacturing and secure the doses needed for the Facility. CEPI is leading COVAX vaccine research and development work, which aims to develop at least three safe and effective vaccines which can be made available to economies participating in the COVAX Facility. Nine candidate vaccines are currently being supported by CEPI; eight of which are currently in clinical trials.“This is a landmark moment in the history of public health with the international community coming together to tackle this pandemic. The global spread of COVID-19 means that it is only through equitable and simultaneous access to new lifesaving COVID-19 vaccines that we can hope to end this pandemic”, said Dr Richard Hatchett, CEO of CEPI. “Countries coming together in this way shows a unity of purpose and resolve to end the acute phase of this pandemic, and we must now work closely with vaccine manufacturers—who play an integral part in the global response—to put in place the agreements needed to fulfil COVAX’s core aim: to have two billion vaccine doses available by the end of 2021. Today, we have taken a great leap towards that goal, for the benefit of all.”The success of COVAX hinges not only on economies signing up to the COVAX Facility and commitments from vaccine manufacturers, but also filling key funding gaps for both COVAX research and development (R&D) work and the Gavi COVAX AMC to support participation of lower income economies in the COVAX Facility.Governments, vaccine manufacturers (in addition to their own R&D), organisations and individuals have committed US$ 1.4 billion towards vaccine R&D so far, but a further US$ 700-800 million is urgently needed to continue to move the portfolio forward in addition to US$ 300 million to fund WHO’s SOLIDARITY trial.The Gavi COVAX AMC has raised around US$ 700 million from sovereign donors as well as philanthropy and the private sector, against an initial target of US$ 2 billion in seed funding needed by the end of 2020. Funding the Gavi COVAX AMC will be critical to ensuring ability to pay is not a barrier to accessing COVID-19 vaccines, a situation which would leave the majority of the world unprotected, with the pandemic and its impact continuing unabated.The Commitment Agreements also commit higher income governments to provide an upfront payment to reserve doses by 9 October 2020. These funds will be used to accelerate the scale-up of vaccine manufacturing to secure two billion doses of vaccine, enough to vaccinate one billion people assuming the vaccine requires a two-dose regimen. Further details on these upfront payments are available in Gavi’s COVAX Facility Explainer. As well as procuring doses for participating economies, the COVAX Facility will also maintain a buffer of doses for emergency and humanitarian use.Participating country comments“COVID-19 poses serious health concerns to people everywhere, and that’s why Canada is committed to working with partners around the world to end the pandemic,” said the Rt. Hon. Justin Trudeau, Prime Minister of Canada. “Equitable, timely, and affordable access to a safe and effective COVID vaccine will be critical to help protect people’s health. Canada supports the objectives and principles of the COVAX Facility as the only global pooled procurement mechanism for countries to collaborate on this monumental undertaking. Our country is a part of this important global response.” “New Zealand’s commitment to the COVAX Facility supports access to vaccines against COVID-19 for other countries too,” said Rt Hon Jacinda Ardern, Prime Minister of New Zealand. “COVAX and the idea of equal access to a COVID-19 vaccine, regardless of ability to pay, is not just a moral imperative, it is the only practical solution to this pandemic. Protecting everyone is the only way we can return our world – our trade, tourism, travel, business – to normal,” said the Honourable Dr Edwin G. Dikoloti, Minister of Health and Wellness for Botswana. “We urge those countries who have not yet signed up to do so. Let us work together to protect each other.” “Immunisation saves lives. Investing in immunisation infrastructure helps strengthen health systems. We have seen this time and again through our work with Gavi and Alliance partners,” said Dr Lia Tadesse, Minister of Health for Ethiopia. “By being a part of the COVAX Facility and the AMC we can continue this work and protect our citizens - and the world - against the impact of COVID-19.” “With COVAX, the world is joining forces and proving that together, we are stronger – and together, we can defeat this pandemic,” said Ekaterine Tikaradze, Minister of Health for Georgia. “Georgia will be joining the COVAX Facility to give our citizens the best chance at having access to safe vaccines. By doing this, we also make sure health care workers and other high risk persons all over the world have access to these life-saving tools, helping to bring the pandemic under control – and we can all recover and rebuild.”“Joining the COVAX Facility was not a difficult decision – not only will this give Kuwaiti citizens access to COVID-19 vaccines as they become available, it will also mean our friends and partners outside our borders also get access,” said His Excellency Sheikh Dr Basel Humoud Al-Sabah, Minister of Health of the State of Kuwait. “We need a global solution to this global pandemic: we believe COVAX is that solution.”“We believe international cooperation – a global effort – is key,” said Dag-Inge Ulstein, Minister of International Development for Norway. “We must continue to work for equitable access to vaccines, tests and treatments. To defeat the coronavirus pandemic, well-off countries need to act swiftly and boldly to make vaccines and treatments available to those who cannot afford to pay themselves. With the commitments to the COVAX facility we are heading in the right direction.”“This is a hugely important initiative, which could offer us a path out of the acute phase of this pandemic and a return to normality,” said His Excellency Dr Ahmed Mohammed Obaid Al Saidi, Minister of Health of the Sultanate of Oman. “I would urge every country that has not yet done so to sign up, for all our sakes. It is far better for us to work together than apart.”Partner comments“The history of vaccines will be defined by our response to COVID-19; the COVAX facility is at the epicenter of this response. Industry is at the forefront in vaccines development and manufacturing leading to supplies of several billion doses within the next few years”, said Mr. Sai D. Prasad, President of the Developing Countries Vaccine Manufacturers’ Network (DCVMN). “The COVAX facility will have a major impact on lives, livelihoods and accelerate the return to normalcy for countries. The DCVMN is fully engaged with its partners to enhance its mission of global public health and to leave no one behind.” “It is very encouraging to see so many countries move from talk to full commitment,” said Thomas Cueni, Director General of the International Federation of Pharmaceutical Manufacturers (IFPMA). “The Facility can only work, and equitable access can only be achieved, if there is solidarity between rich and poorer countries. Today vaccine makers who have the unique skills and expertise to scale up manufacturing to levels never seen before, stand ready, together, to take up the challenge of providing two billion doses of yet unknown COVID-19 vaccines. This is no mean feat, as it requires doubling existing capacity in record time. Today, marks a significant step forward, and is a historic mark of solidarity which has the power to bring the acute phase of this pandemic to an end; and we are proud to be part of this unique endeavour to leave no one behind.”“Uniting our efforts through COVAX must guarantee fair allocation and equitable delivery of the COVID-19 vaccine to those who need it most, and not just those who can afford it,” said Jagan Chapagain, Secretary-General of the International Federation of Red Cross and Red Crescent Societies. “We all have a moral and public health imperative to protect the poor in rural communities as the affluent in cities, the old in care homes as the young in refugee camps. The power of our humanity and the success of COVAX will be measured by how we collectively protect the most vulnerable among us.""Global cooperation must be the cornerstone of our global response to COVID-19,” said Kevin Watkins, Chief Executive of Save the Children. “The COVAX Facility has the potential to help ensure universal and equitable access to future COVID vaccines. For this to happen, we need to ensure people in low- and middle-income countries get their fair share and can access the vaccines they need to help overcome the biggest public health and child rights crisis of our generation."“Seeing such unity in the face of the COVID-19 crisis gives us confidence that, together, we can ensure the equitable delivery of COVID vaccines globally,” said Henrietta Fore, UNICEF Executive Director. “With our globe-spanning supply chain and on-the-ground presence across 190 countries, UNICEF is proud to support this historic effort.” Notes to editorsA COVAX Facility Explainer document is available on the Gavi website here:, as well as a Q&A from Gavi CEO Seth Berkley here.The full list of fully self-financing economies that have submitted both binding Commitment Agreements and non-binding Confirmations of Intent to Participate, as well as the 92 low- and middle-income countries eligible for the Gavi COVAX AMC, is available here.About Gavi, the Vaccine AllianceGavi, the Vaccine Alliance is a public-private partnership that helps vaccinate half the world’s children against some of the world’s deadliest diseases. Since its inception in 2000, Gavi has helped to immunise a whole generation – over 760 million children – and prevented more than 13 million deaths, helping to halve child mortality in 73 developing countries. Gavi also plays a key role in improving global health security by supporting health systems as well as funding global stockpiles for Ebola, cholera, meningitis and yellow fever vaccines. After two decades of progress, Gavi is now focused on protecting the next generation and reaching the unvaccinated children still being left behind, employing innovative finance and the latest technology – from drones to biometrics – to save millions more lives, prevent outbreaks before they can spread and help countries on the road to self-sufficiency. Learn more at www.gavi.org and connect with us on Facebook and Twitter.The Vaccine Alliance brings together developing country and donor governments, the World Health Organization, UNICEF, the World Bank, the vaccine industry, technical agencies, civil society, the Bill & Melinda Gates Foundation and other private sector partners. View the full list of donor governments and other leading organizations that fund Gavi’s work here.About CEPICEPI is an innovative partnership between public, private, philanthropic, and civil organisations, launched at Davos in 2017, to develop vaccines to stop future epidemics. CEPI has moved with great urgency and in coordination with WHO in response to the emergence of COVID-19. CEPI has initiated nine partnerships to develop vaccines against the novel coronavirus. The programmes are leveraging rapid response platforms already supported by CEPI as well as new partnerships.Before the emergence of COVID-19, CEPI’s priority diseases included Ebola virus, Lassa virus, Middle East Respiratory Syndrome coronavirus, Nipah virus, Rift Valley Fever and Chikungunya virus. CEPI also invested in platform technologies that can be used for rapid vaccine and immunoprophylactic development against unknown pathogens (Disease X).About WHOThe World Health Organization provides global leadership in public health within the United Nations system. Founded in 1948, WHO works with 194 Member States, across six regions and from more than 150 offices, to promote health, keep the world safe and serve the vulnerable. Our goal for 2019-2023 is to ensure that a billion more people have universal health coverage, to protect a billion more people from health emergencies, and provide a further billion people with better health and wellbeing.For updates on COVID-19 and public health advice to protect yourself from coronavirus, visit www.who.int and follow WHO on Twitter, Facebook, Instagram, LinkedIn, TikTok, Pinterest, Snapchat, YouTubeAbout ACT-AcceleratorThe Access to COVID-19 Tools ACT-Accelerator, is a new, ground-breaking global collaboration to accelerate the development, production, and equitable access to COVID-19 tests, treatments, and vaccines. It was set up in response to a call from G20 leaders in March and launched by the WHO, European Commission, France and The Bill & Melinda Gates Foundation in April 2020.The ACT-Accelerator is not a decision-making body or a new organisation, but works to speed up collaborative efforts among existing organisations to end the pandemic. It is a framework for collaboration that has been designed to bring key players around the table with the goal of ending the pandemic as quickly as possible through the accelerated development, equitable allocation, and scaled up delivery of tests, treatments and vaccines, thereby protecting health systems and restoring societies and economies in the near term. It draws on the experience of leading global health organisations which are tackling the world’s toughest health challenges, and who, by working together, are able to unlock new and more ambitious results against COVID-19. Its members share a commitment to ensure all people have access to all the tools needed to defeat COVID-19 and to work with unprecedented levels of partnership to achieve it.The ACT-Accelerator has four areas of work: diagnostics, therapeutics, vaccines and the health system connector. Cross-cutting all of these is the workstream on Access & Allocation. More information on the ACT Accelerator is available here.
GDG Virtual Meeting on the update of the Consolidated Guidelines for use of antiretrovirals for preventing and treating HIV infection - service delivery
WHO has made available the membership of the Guidelines Development Group (GDG) for the update of the service delivery component of the WHO "Consolidated Guidelines for use of antiretrovirals for preventing and treating HIV infection."
“Let’s Talk About Dementia” campaign for the Americas - one year on
In September 2019, the Pan American Health Organization (PAHO), in partnership with Alzheimer’s Disease International (ADI), launched the “Let’s Talk About Dementia” campaign in the Americas. The campaign aimed to encourage people to talk more openly about dementia. Campaign materials, including posters and social media cards, were made available in Dutch, English, French, Portuguese and Spanish. They not only highlighted the importance of talking about dementia, but also communicated the signs that can be an indication of dementia and ways to reduce risk factors for the disease.